Ilya Lipkovich
2011
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.
Whom Ilya Lipkovich trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Ilya Lipkovich overall
Papers from Ilya Lipkovich's perspective
Ordered by how strongly the researchers Ilya Lipkovich trusts endorse each paper. Same corpus, a different order for every researcher.
- Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. (Journal of Clinical Oncology)
- K-ras mutations and benefit from cetuximab in advanced colorectal cancer. (New England Journal of Medicine)
- Classification and regression trees
- Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. (Journal of Clinical Oncology)
- Multiple Comparison Procedures
- Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. (New England Journal of Medicine)
- Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. (New England Journal of Medicine)
- Bump hunting in high-dimensional data
- The method of minimization for allocation to clinical trials. a review. (Controlled Clinical Trials)
- Classification and Regression Trees